{
Markus Renschler

People

}
001122334455554433221100
001122334455554433221100

light horse therapeutics secures 62 million and partners with novartis

Light Horse Therapeutics has secured $62 million in Series A financing and formed a partnership with Novartis, which includes a $25 million upfront payment and potential milestone payments of up to $1 billion. The biotech aims to revolutionize drug discovery with its genetic editing-based platform, initially focusing on challenging oncology targets while exploring other therapeutic areas in the future.
Yahoo Finance
United States Dollar Bristol-Myers Squibb Co Novartis AG ABBVIE ARE USA John Tallarico Markus Renschler Show more
Finance & Economy, Press Release
13:38 10.01.2025

light horse therapeutics launched with 62 million funding and novartis partnership

Light Horse Therapeutics has launched with $62 million in Series A financing led by Versant Ventures, alongside partners including Novartis. The company focuses on developing small molecule therapeutics using a precision gene editing platform to tackle challenging oncology targets, with potential for broader applications. The collaboration with Novartis includes a $25 million upfront payment and up to $1 billion in milestone payments, aiming to create first-in-class therapies.
World Pharmaceutical Frontiers
United States Dollar Bristol-Myers Squibb Co Novartis AG ABBVIE ARE JPN USA Ben Cravatt Brian Liau Markus Renschler John Tallarico Nathanael Gray Show more
Healthcare, Press Release
13:38 10.01.2025

light horse therapeutics partners with novartis for innovative cancer drug development

Light Horse Therapeutics has entered a strategic collaboration with Novartis, securing a $25 million upfront payment and the potential for up to $1 billion in milestone payments for research, development, and sales. This partnership aims to leverage Light Horse's innovative platform to develop first-in-class therapeutics, particularly targeting challenging oncology areas. The collaboration is expected to accelerate the creation of novel cancer treatments, utilizing advanced genetic screening and proprietary chemical libraries.
BioSpace
Novartis AG John Tallarico Markus Renschler
Technology & Innovation, Press Release
16:15 09.01.2025

light horse therapeutics secures funding and partnership with novartis

Light Horse Therapeutics has launched with a $62-million series A financing and a collaboration with Novartis potentially worth over $1 billion. The San Diego-based biotech employs a "function-first" approach to drug discovery, focusing initially on oncology targets while integrating precision genome editing techniques. The partnership includes a $25-million upfront payment and opportunities for significant R&D and sales milestones.
firstwordpharma.com
United States Dollar Bristol-Myers Squibb Co Novartis AG ABBVIE USA Ben Cravatt Laure Escoubet Brian Liau Markus Renschler John Tallarico Nathanael Gray Show more
Technology & Innovation, News Article
16:13 09.01.2025
Trending
Subcategory
Corporate News Stock Market Updates Industry Trends Finance Mergers & Acquisitions Industry Mergers & Acquisitions Financial Scams and Security Market Analysis and Predictions Global Financial Events Retail and Consumer Goods Global Trade Developments Banking Regulations CEO Changes AI Innovations Supply Chain Management Hedge Funds & Private Equity Central Bank Actions Startups & Entrepreneurship Funding Rounds & Investments Government Economic Policies Energy Sector Developments
Countries:
USA CHN IND GBR CHE DEU TWN CAN ARE ITA JPN FRA SGP RUS NLD VNM HKG THA SAU IRL
Companies:
Barclays PLC NVIDIA Corporation Tesla, Inc. JPMorgan Chase & Co. Morgan Stanley Apple Inc. The Goldman Sachs Group, Inc. Capital One Financial Corporation Wells Fargo & Company Huawei Technologies CO. Ltd. Bank of America Corporation UBS Group AG UniCredit S.p.A. Tesmec S.p.A. Banco BPM S.p.A. Deutsche Bank RV Global PP HSBC Holdings plc Netflix, Inc. Credit Suisse Real Estate Fund Siat Citigroup Inc.
Currencies:
United States Dollar Euro Indian Rupee Chinese Yuan Swiss Franc British Pound Sterling United Arab Emirates Dirham Japanese Yen Hong Kong Dollar Danish Krone South Korean Won Canadian Dollar Singapore Dollar Australian Dollar Offshore Chinese Yuan Russian Ruble Vietnamese Đồng Brazilian Real Colombian Peso Malaysian Ringgit
People:
Donald Trump Elon Musk Jerome Powell Dan Ives Joe Biden Paul Triolo Warren Buffett Tom O'Malley Akhil Gupta Jamie Dimon Raja Akram Jensen Huang Mihir Doshi Soha Nashaat Andrea Orcel Troy L Rohrbaugh Kevin Hassett Patrick Ramsey Ian Rockliffe Brandt Montour

Machinary offers a groundbreaking, modular, and customizable solution that provides advanced financial news and statistical analysis. Our platform goes beyond traditional quantitative analysis, offering users a comprehensive understanding of real-time market dynamics, event detection, and risk analysis.

Links

Address

Newsletter

© 2025 by Machinary.com - Version: 1.0.0.0. All rights reserved

Layout

Color mode

Theme mode

Layout settings

Save settings
Reset settings
Seems like the connection with the server has been lost. It can be due to poor or broken network. Please hang on while we're trying to reconnect...
Oh snap! Failed to reconnect with the server. This is typically caused by a longer network outage, or if the server has been taken down. You can try to reconnect, but if that does not work, you need to reload the page.
Oh man! The server rejected the attempt to reconnect. The only option now is to reload the page, but be prepared that it won't work, since this is typically caused by a failure on the server.